Georges Pasquet
10Patents
4h-index
9Co-inventors
53Inventor score
Filing activity: Sep 19, 1989 → Mar 18, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7262201B1 | Quinazoline derivatives | Chemistry; Metallurgy | 37 | Expired |
| US5013731A | Cephalosporin compounds | Chemistry; Metallurgy | 14 | Expired |
| US7402585B2 | Substituted quinazoline derivatives as inhibitors of aurora kinases | Chemistry; Metallurgy | 9 | Expired |
| US5049558A | Cephalosporin derivatives | Chemistry; Metallurgy | 4 | Expired |
| US5254679A | Cephalosporin intermediates | Chemistry; Metallurgy | 2 | Expired |
| US9018191B2 | Phosphonoxy quinazoline derivatives and their pharmaceutical use | Chemistry; Metallurgy | 1 | Active |
| US9567358B2 | Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide | Chemistry; Metallurgy | 0 | Active |
| US8268841B2 | Phosphonoxy quinazoline derivatives and their pharmaceutical use | Chemistry; Metallurgy | 0 | Active |
| US5053500A | Intermediates for the preparation of beta-lactam antibiotics | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7691867B2 | Chemical compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.